摘要
目的评估植入125I粒子治疗中央型肺癌的临床价值。方法56例确诊的晚期中央型肺癌患者，经纤维支气管镜引导植入125I粒子，定期复查，观察疗效及不良反应。结果56例中央型肺癌患者经治疗总有效率达76．78％，肺不张复张有效率为90．90％。结论125I粒子经纤维支气管镜植入治疗晚期中央型肺癌有效，且安全可行。
Objective To explore the temporal curative effect of 125I seed implantation in advanced stage central type lung cancer. Methods 125I seed was implanted in 56 patients confirmed advanced stage central type lung cancer via fibrobronehoseope and all eases were fellow up in certain duration to explore their efficacies and the adverse reaction. Results Total efficient rate was 76.78% in 56 patients. Lung reexpanded rate was 90.90%. Conclusion The therapy of 125I seed implantation in advanced stage central type lung cancer is safe and available.
出处
《国际放射医学核医学杂志》
2009年第5期291-292,共2页
International Journal of Radiation Medicine and Nuclear Medicine
